Facioscapulohumeral Muscular Dystrophy (FSHD) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
Conditions: Facioscapulohumeral Muscular Dystrophy; Limb Girdle Muscular DystrophyIntervention: Drug: ATYR1940Sponsor: aTyr Pharma, Inc.Enrolling by invitation - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2016 Category: Research Source Type: clinical trials
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy
< b > Conditions < /b > : Facioscapulohumeral Muscular Dystrophy; Limb Girdle Muscular Dystrophy < br/ > < b > Intervention < /b > : Drug: ATYR1940 < br/ > < b > Sponsor < /b > : aTyr Pharma, Inc. < br/ > < b > Enrolling by invitation < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 30, 2016 Category: Research Source Type: clinical trials
Facioscapulohumeral Dystrophy in Children
Conditions: Neurological Observations; Facioscapulohumeral Muscular Dystrophy; Pediatric DisorderIntervention: Sponsors: University Medical Center Nijmegen; Leiden University Medical Center; Princess Beatrix Muscle FoundationRecruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2015 Category: Research Source Type: clinical trials
